Federation Des Caisses Desjardins Du Quebec Biogen Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Biogen Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 11,396 shares of BIIB stock, worth $1.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,396
Previous 10,104
12.79%
Holding current value
$1.61 Million
Previous $1.96 Million
11.03%
% of portfolio
0.01%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding BIIB
# of Institutions
1,006Shares Held
126MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.37 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.27 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.06 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.05 Billion0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$523 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...